Research indicates that vitamin D supplementation during pregnancy positively impacts children’s bone health and lean mass, with potential long-term benefits.
FDA rejects Alnylam’s heart disease treatment over insufficient data
The Food and Drug Administration rejected an Alnylam Pharmaceuticals’ therapy for an increasingly prevalent heart disease, the company said Monday, citing insufficient evidence that the